nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCB1—adrenal gland cancer	0.897	1	CbGaD
Lansoprazole—CYP2C19—urine—adrenal gland cancer	0.00476	0.116	CbGeAlD
Lansoprazole—MAPT—pituitary gland—adrenal gland cancer	0.00392	0.0954	CbGeAlD
Lansoprazole—CYP1A2—urine—adrenal gland cancer	0.00388	0.0944	CbGeAlD
Lansoprazole—CYP2C9—urine—adrenal gland cancer	0.00369	0.0896	CbGeAlD
Lansoprazole—ATP4A—adrenal cortex—adrenal gland cancer	0.00361	0.0877	CbGeAlD
Lansoprazole—MAPT—adrenal gland—adrenal gland cancer	0.00351	0.0852	CbGeAlD
Lansoprazole—CYP3A4—urine—adrenal gland cancer	0.00281	0.0683	CbGeAlD
Lansoprazole—CYP2D6—urine—adrenal gland cancer	0.00277	0.0672	CbGeAlD
Lansoprazole—ATP4A—adrenal gland—adrenal gland cancer	0.0026	0.0633	CbGeAlD
Lansoprazole—Pantoprazole—ABCB1—adrenal gland cancer	0.00234	0.551	CrCbGaD
Lansoprazole—Omeprazole—ABCB1—adrenal gland cancer	0.00191	0.449	CrCbGaD
Lansoprazole—CYP1B1—gonad—adrenal gland cancer	0.00119	0.0289	CbGeAlD
Lansoprazole—CYP1B1—pituitary gland—adrenal gland cancer	0.00116	0.0282	CbGeAlD
Lansoprazole—ABCG2—adrenal cortex—adrenal gland cancer	0.00107	0.026	CbGeAlD
Lansoprazole—CYP1B1—adrenal gland—adrenal gland cancer	0.00104	0.0252	CbGeAlD
Lansoprazole—MAPT—Apoptotic cleavage of cellular proteins—CTNNB1—adrenal gland cancer	0.000934	0.0162	CbGpPWpGaD
Lansoprazole—CYP2C8—pituitary gland—adrenal gland cancer	0.000888	0.0216	CbGeAlD
Lansoprazole—ABCG2—pituitary gland—adrenal gland cancer	0.000864	0.021	CbGeAlD
Lansoprazole—CYP1A1—cardiac atrium—adrenal gland cancer	0.000839	0.0204	CbGeAlD
Lansoprazole—CYP4A11—PPARA activates gene expression—MED12—adrenal gland cancer	0.000813	0.0141	CbGpPWpGaD
Lansoprazole—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.000795	0.0138	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—BAD—adrenal gland cancer	0.00079	0.0137	CbGpPWpGaD
Lansoprazole—ABCG2—adrenal gland—adrenal gland cancer	0.000772	0.0188	CbGeAlD
Lansoprazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00075	0.013	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000748	0.013	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—PRKACA—adrenal gland cancer	0.00073	0.0126	CbGpPWpGaD
Lansoprazole—CYP1B1—Endogenous sterols—POMC—adrenal gland cancer	0.000729	0.0126	CbGpPWpGaD
Lansoprazole—MAPT—Apoptotic execution phase—CTNNB1—adrenal gland cancer	0.000726	0.0126	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—CDC42—adrenal gland cancer	0.0007	0.0121	CbGpPWpGaD
Lansoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000664	0.0115	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—CDC42—adrenal gland cancer	0.000619	0.0107	CbGpPWpGaD
Lansoprazole—MAPT—LKB1 signaling events—TP53—adrenal gland cancer	0.000562	0.00975	CbGpPWpGaD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.000548	0.0095	CbGpPWpGaD
Lansoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—adrenal gland cancer	0.000528	0.00915	CbGpPWpGaD
Lansoprazole—ABCB1—adrenal cortex—adrenal gland cancer	0.000527	0.0128	CbGeAlD
Lansoprazole—CYP4A11—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000525	0.0091	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000524	0.00908	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—BAD—adrenal gland cancer	0.000489	0.00847	CbGpPWpGaD
Lansoprazole—MAPT—LPA receptor mediated events—EGFR—adrenal gland cancer	0.000487	0.00844	CbGpPWpGaD
Lansoprazole—CYP4A11—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000485	0.0084	CbGpPWpGaD
Lansoprazole—MAPT—Copper homeostasis—TP53—adrenal gland cancer	0.000483	0.00837	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—BAD—adrenal gland cancer	0.000461	0.00798	CbGpPWpGaD
Lansoprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000459	0.00796	CbGpPWpGaD
Lansoprazole—ABCB1—gonad—adrenal gland cancer	0.000437	0.0106	CbGeAlD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000427	0.00739	CbGpPWpGaD
Lansoprazole—CYP4A11—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000426	0.00738	CbGpPWpGaD
Lansoprazole—ABCB1—pituitary gland—adrenal gland cancer	0.000426	0.0104	CbGeAlD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.000416	0.00721	CbGpPWpGaD
Lansoprazole—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000411	0.00712	CbGpPWpGaD
Lansoprazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00041	0.00711	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000406	0.00704	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—BRAF—adrenal gland cancer	0.000393	0.00681	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00039	0.00676	CbGpPWpGaD
Lansoprazole—ABCB1—adrenal gland—adrenal gland cancer	0.000381	0.00925	CbGeAlD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00038	0.00659	CbGpPWpGaD
Lansoprazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000375	0.0065	CbGpPWpGaD
Lansoprazole—CYP2C18—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000372	0.00645	CbGpPWpGaD
Lansoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000359	0.00622	CbGpPWpGaD
Lansoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000357	0.00619	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000356	0.00617	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000346	0.00599	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—TP53—adrenal gland cancer	0.000346	0.00599	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000339	0.00588	CbGpPWpGaD
Lansoprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000339	0.00587	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000334	0.00579	CbGpPWpGaD
Lansoprazole—CYP1A1—PPARA activates gene expression—MED12—adrenal gland cancer	0.000323	0.00559	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000322	0.00557	CbGpPWpGaD
Lansoprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.000316	0.00547	CbGpPWpGaD
Lansoprazole—CYP1B1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000312	0.00541	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000308	0.00534	CbGpPWpGaD
Lansoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000305	0.00529	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—CTNNB1—adrenal gland cancer	0.000303	0.00525	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000302	0.00524	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000287	0.00497	CbGpPWpGaD
Lansoprazole—CYP1B1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000274	0.00476	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000257	0.00444	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00025	0.00434	CbGpPWpGaD
Lansoprazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000247	0.00428	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000239	0.00414	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000237	0.0041	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000237	0.0041	CbGpPWpGaD
Lansoprazole—ABCG2—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000236	0.00409	CbGpPWpGaD
Lansoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000236	0.00408	CbGpPWpGaD
Lansoprazole—CYP4A11—Biological oxidations—POMC—adrenal gland cancer	0.000226	0.00392	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000225	0.0039	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000222	0.00385	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000218	0.00378	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.000217	0.00377	CbGpPWpGaD
Lansoprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000209	0.00361	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000206	0.00356	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000203	0.00352	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—SDHB—adrenal gland cancer	0.000202	0.00351	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TP53—adrenal gland cancer	0.000202	0.00349	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—POMC—adrenal gland cancer	0.000198	0.00343	CbGpPWpGaD
Lansoprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000192	0.00333	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000192	0.00333	CbGpPWpGaD
Lansoprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000191	0.00331	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000189	0.00328	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—SDHB—adrenal gland cancer	0.000177	0.00306	CbGpPWpGaD
Lansoprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000176	0.00306	CbGpPWpGaD
Lansoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000171	0.00296	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000171	0.00296	CbGpPWpGaD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000169	0.00293	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00016	0.00277	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000159	0.00276	CbGpPWpGaD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000157	0.00273	CbGpPWpGaD
Lansoprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000157	0.00272	CbGpPWpGaD
Lansoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000156	0.0027	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000155	0.00269	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000146	0.00253	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000146	0.00253	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—POMC—adrenal gland cancer	0.000146	0.00253	CbGpPWpGaD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000144	0.00249	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000141	0.00244	CbGpPWpGaD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000138	0.0024	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000137	0.00238	CbGpPWpGaD
Lansoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000133	0.0023	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000131	0.00227	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—SDHB—adrenal gland cancer	0.00013	0.00226	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—RRM1—adrenal gland cancer	0.00013	0.00226	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—SDHD—adrenal gland cancer	0.00013	0.00226	CbGpPWpGaD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000127	0.0022	CbGpPWpGaD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000126	0.00219	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000123	0.00213	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—SDHB—adrenal gland cancer	0.000119	0.00206	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—RRM1—adrenal gland cancer	0.000114	0.00197	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—SDHD—adrenal gland cancer	0.000114	0.00197	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000108	0.00187	CbGpPWpGaD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000103	0.00178	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000103	0.00178	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—MED12—adrenal gland cancer	9.72e-05	0.00168	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	9.3e-05	0.00161	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	9.3e-05	0.00161	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—POMC—adrenal gland cancer	8.98e-05	0.00156	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	8.88e-05	0.00154	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.69e-05	0.00151	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.66e-05	0.0015	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—MED12—adrenal gland cancer	8.5e-05	0.00147	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—SDHD—adrenal gland cancer	8.4e-05	0.00146	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—RRM1—adrenal gland cancer	8.4e-05	0.00146	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	8.32e-05	0.00144	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	8.23e-05	0.00143	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SDHB—adrenal gland cancer	8.03e-05	0.00139	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	7.94e-05	0.00138	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—SDHD—adrenal gland cancer	7.64e-05	0.00132	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—RRM1—adrenal gland cancer	7.64e-05	0.00132	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SDHB—adrenal gland cancer	7.36e-05	0.00128	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	7.35e-05	0.00127	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	7.19e-05	0.00125	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	7.15e-05	0.00124	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PRKACA—adrenal gland cancer	7.09e-05	0.00123	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	7.09e-05	0.00123	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	7.06e-05	0.00122	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.93e-05	0.0012	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	6.76e-05	0.00117	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	6.7e-05	0.00116	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SDHB—adrenal gland cancer	6.57e-05	0.00114	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	6.46e-05	0.00112	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SDHB—adrenal gland cancer	6.41e-05	0.00111	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.32e-05	0.00109	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MED12—adrenal gland cancer	6.26e-05	0.00109	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PRKACA—adrenal gland cancer	6.2e-05	0.00107	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SDHB—adrenal gland cancer	6.04e-05	0.00105	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SDHB—adrenal gland cancer	5.99e-05	0.00104	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.79e-05	0.001	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GNAS—adrenal gland cancer	5.75e-05	0.000996	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	5.73e-05	0.000992	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MED12—adrenal gland cancer	5.7e-05	0.000987	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ABCB1—adrenal gland cancer	5.64e-05	0.000977	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	5.6e-05	0.00097	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.52e-05	0.000957	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	5.26e-05	0.000911	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—RRM1—adrenal gland cancer	5.17e-05	0.000896	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SDHD—adrenal gland cancer	5.17e-05	0.000896	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.17e-05	0.000896	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SDHB—adrenal gland cancer	5.12e-05	0.000887	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GNAS—adrenal gland cancer	5.02e-05	0.00087	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ABCB1—adrenal gland cancer	4.93e-05	0.000854	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.8e-05	0.000831	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—RRM1—adrenal gland cancer	4.74e-05	0.000822	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SDHD—adrenal gland cancer	4.74e-05	0.000822	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.71e-05	0.000817	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.71e-05	0.000816	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PRKACA—adrenal gland cancer	4.57e-05	0.000792	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.47e-05	0.000774	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	4.42e-05	0.000766	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SDHD—adrenal gland cancer	4.23e-05	0.000734	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—RRM1—adrenal gland cancer	4.23e-05	0.000734	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PRKACA—adrenal gland cancer	4.16e-05	0.00072	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—RRM1—adrenal gland cancer	4.13e-05	0.000716	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SDHD—adrenal gland cancer	4.13e-05	0.000716	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.03e-05	0.000698	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SDHB—adrenal gland cancer	3.95e-05	0.000685	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—RRM1—adrenal gland cancer	3.89e-05	0.000675	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SDHD—adrenal gland cancer	3.89e-05	0.000675	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.89e-05	0.000674	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—POMC—adrenal gland cancer	3.87e-05	0.00067	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—RRM1—adrenal gland cancer	3.86e-05	0.000669	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SDHD—adrenal gland cancer	3.86e-05	0.000669	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MED12—adrenal gland cancer	3.86e-05	0.000668	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.73e-05	0.000646	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GNAS—adrenal gland cancer	3.7e-05	0.000642	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ABCB1—adrenal gland cancer	3.63e-05	0.00063	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MED12—adrenal gland cancer	3.54e-05	0.000613	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.45e-05	0.000597	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—POMC—adrenal gland cancer	3.38e-05	0.000586	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GNAS—adrenal gland cancer	3.37e-05	0.000584	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ABCB1—adrenal gland cancer	3.31e-05	0.000573	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—RRM1—adrenal gland cancer	3.3e-05	0.000572	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SDHD—adrenal gland cancer	3.3e-05	0.000572	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.16e-05	0.000548	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MED12—adrenal gland cancer	3.16e-05	0.000547	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.13e-05	0.000543	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—adrenal gland cancer	3.09e-05	0.000535	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MED12—adrenal gland cancer	3.08e-05	0.000534	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MED12—adrenal gland cancer	2.9e-05	0.000503	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MED12—adrenal gland cancer	2.88e-05	0.000499	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.82e-05	0.000489	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	2.81e-05	0.000488	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.75e-05	0.000477	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—adrenal gland cancer	2.7e-05	0.000467	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	2.58e-05	0.000447	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.57e-05	0.000446	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—RRM1—adrenal gland cancer	2.55e-05	0.000441	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SDHD—adrenal gland cancer	2.55e-05	0.000441	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.52e-05	0.000437	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—POMC—adrenal gland cancer	2.49e-05	0.000432	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MED12—adrenal gland cancer	2.46e-05	0.000426	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.3e-05	0.000399	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GNAS—adrenal gland cancer	2.28e-05	0.000395	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—POMC—adrenal gland cancer	2.27e-05	0.000393	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.25e-05	0.00039	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.25e-05	0.000389	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	2.24e-05	0.000388	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.2e-05	0.000381	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.12e-05	0.000367	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	2.1e-05	0.000364	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GNAS—adrenal gland cancer	2.09e-05	0.000362	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.05e-05	0.000356	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	2.05e-05	0.000356	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—adrenal gland cancer	1.99e-05	0.000345	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.9e-05	0.000329	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.87e-05	0.000323	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.83e-05	0.000317	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.82e-05	0.000316	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—adrenal gland cancer	1.81e-05	0.000314	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.79e-05	0.000311	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.75e-05	0.000304	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.72e-05	0.000297	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GNAS—adrenal gland cancer	1.7e-05	0.000295	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.68e-05	0.000292	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	1.67e-05	0.000289	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—adrenal gland cancer	1.54e-05	0.000266	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.45e-05	0.000252	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.43e-05	0.000247	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—adrenal gland cancer	1.41e-05	0.000244	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.38e-05	0.00024	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.26e-05	0.000218	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—adrenal gland cancer	1.23e-05	0.000213	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	1.22e-05	0.000212	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.16e-05	0.0002	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.15e-05	0.000199	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	1.12e-05	0.000195	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.12e-05	0.000194	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.1e-05	0.000191	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1e-05	0.000174	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—adrenal gland cancer	9.79e-06	0.00017	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—adrenal gland cancer	9.78e-06	0.00017	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	9.22e-06	0.00016	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	9.14e-06	0.000158	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	7.81e-06	0.000135	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—adrenal gland cancer	7.56e-06	0.000131	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	6.03e-06	0.000104	CbGpPWpGaD
